- Home
- ALKT vs ALKS Comparison
ALKT vs ALKS Comparison
Compare ALKT & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALKT
- ALKS
- Stock Information
- Founded
- ALKT 2007
- ALKS 1987
- Country
- ALKT United States
- ALKS Ireland
- Employees
- ALKT N/A
- ALKS N/A
- Industry
- ALKT EDP Services
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- ALKT Technology
- ALKS Health Care
- Exchange
- ALKT Nasdaq
- ALKS Nasdaq
- Market Cap
- ALKT 4.1B
- ALKS 4.9B
- IPO Year
- ALKT 2021
- ALKS 1991
- Fundamental
- Price
- ALKT $38.71
- ALKS $29.71
- Analyst Decision
- ALKT Buy
- ALKS Buy
- Analyst Count
- ALKT 8
- ALKS 12
- Target Price
- ALKT $41.50
- ALKS $35.42
- AVG Volume (30 Days)
- ALKT 1.0M
- ALKS 1.7M
- Earning Date
- ALKT 10-30-2024
- ALKS 02-13-2025
- Dividend Yield
- ALKT N/A
- ALKS N/A
- EPS Growth
- ALKT N/A
- ALKS 55.25
- EPS
- ALKT N/A
- ALKS 1.97
- Revenue
- ALKT $315,562,000.00
- ALKS $1,505,121,000.00
- Revenue This Year
- ALKT $28.55
- ALKS N/A
- Revenue Next Year
- ALKT $24.19
- ALKS N/A
- P/E Ratio
- ALKT N/A
- ALKS $13.00
- Revenue Growth
- ALKT 26.73
- ALKS N/A
- 52 Week Low
- ALKT $22.62
- ALKS $22.90
- 52 Week High
- ALKT $42.29
- ALKS $32.88
- Technical
- Relative Strength Index (RSI)
- ALKT 50.20
- ALKS 49.52
- Support Level
- ALKT $37.35
- ALKS $29.65
- Resistance Level
- ALKT $39.99
- ALKS $31.18
- Average True Range (ATR)
- ALKT 1.60
- ALKS 0.87
- MACD
- ALKT -0.21
- ALKS -0.16
- Stochastic Oscillator
- ALKT 43.55
- ALKS 20.38
About ALKT Alkami Technology Inc.
Alkami Technology Inc is a cloud-based digital banking solutions provider. Alkami Platform, allows FIs to onboard and engage new users, accelerate revenues and meaningfully improve operational efficiency with the support of a proprietary, true cloud-based, multi-tenant architecture.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.